Walleye Trading
UBX

Walleye Trading’s Unity Biotechnology UBX Stock Holding History

Walleye Trading’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,096
Closed -$12K – 5683
2022
Q1 		$12K Buy
+1,096
New +$12.3K ﹤0.01% 4902
2021
Q3 		– Sell
-1,638
Closed -$76K – 5745
2021
Q2 		$76K Buy
+1,638
New +$78.9K ﹤0.01% 4482
2020
Q4 		– Sell
-2,601
Closed -$90K – 4946
2020
Q3 		$90K Buy
+2,601
New +$165K ﹤0.01% 3443
2020
Q1 		– Sell
-1,034
Closed -$75K – 4593
2019
Q4 		$75K Buy
+1,034
New +$72.9K ﹤0.01% 3676

Other funds holding UBX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's UBX Position: Q2 2022 in Review

Walleye Trading sold out of Unity Biotechnology (UBX) in Q2 2022, closing a stake of 1,096 shares — an estimated $12K sold.

Walleye Trading first reported a position in UBX in Q4 2019 and held it in 4 quarters. The position peaked at $90K in Q3 2020. 65 funds tracked by Wall St. Rank hold UBX as of Q2 2022.

  • Walleye Trading reported no remaining Unity Biotechnology position as of Q2 2022 after selling out during the quarter.
  • Walleye Trading sold 1,096 Unity Biotechnology shares in Q2 2022, an estimated $12K.
  • Walleye Trading first reported a position in Unity Biotechnology in Q4 2019 and held it in 4 quarters.
  • Walleye Trading's Unity Biotechnology position peaked at $90K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held Unity Biotechnology as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.